{"id":"https://openalex.org/W4406870002","doi":"https://doi.org/10.1200/jco.2025.43.4_suppl.23","title":"Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM).","display_name":"Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM).","publication_year":2025,"publication_date":"2025-01-27","ids":{"openalex":"https://openalex.org/W4406870002","doi":"https://doi.org/10.1200/jco.2025.43.4_suppl.23"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2025.43.4_suppl.23","doi":"https://doi.org/10.1200/jco.2025.43.4_suppl.23","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.4_suppl.23","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061200817","display_name":"Marwan Fakih","orcid":"https://orcid.org/0000-0002-6554-5488","observed_orcids":["https://orcid.org/0000-0002-6554-5488"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marwan Fakih","raw_affiliation_strings":["Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062202820","display_name":"Neil Howard Segal","orcid":"https://orcid.org/0000-0002-3047-2303","observed_orcids":["https://orcid.org/0000-0002-3047-2303"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil Howard Segal","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062338114","display_name":"Benjamin L. Schlechter","orcid":"https://orcid.org/0000-0002-1529-3278","observed_orcids":["https://orcid.org/0000-0002-1529-3278"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin L. Schlechter","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079480540","display_name":"Thierry Andr\u00e9","orcid":"https://orcid.org/0000-0002-5103-7095","observed_orcids":["https://orcid.org/0000-0002-5103-7095"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210102928","display_name":"H\u00f4pital Saint-Antoine","ror":"https://ror.org/01875pg84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Thierry Andre","raw_affiliation_strings":["Saint-Antoine Hospital, AP-HP, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saint-Antoine Hospital, AP-HP, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210102928"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079437223","display_name":"Filippo Pietrantonio","orcid":"https://orcid.org/0000-0002-8530-8420","observed_orcids":["https://orcid.org/0000-0002-8530-8420"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Filippo Pietrantonio","raw_affiliation_strings":["Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010363210","display_name":"Benny Johnson","orcid":"https://orcid.org/0000-0003-3683-8115","observed_orcids":["https://orcid.org/0000-0003-3683-8115","https://orcid.org/0000-0002-6826-6687"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benny Johnson","raw_affiliation_strings":["Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center; Agenus Inc., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center; Agenus Inc., Lexington, MA","institution_ids":["https://openalex.org/I1343551460","https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102014525","display_name":"Alexander V. Vasilyev","orcid":"https://orcid.org/0000-0002-6709-502X","observed_orcids":["https://orcid.org/0000-0002-6709-502X"]},"institutions":[{"id":"https://openalex.org/I2799351582","display_name":"Russian Railways","ror":"https://ror.org/02zjtq409","country_code":"RU","type":"government","lineage":["https://openalex.org/I2799351582"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Alexander Vasilyev","raw_affiliation_strings":["RZD Medicine Clinical Hospital of Saint Petersburg, Saint Petersburg, Russian Federation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RZD Medicine Clinical Hospital of Saint Petersburg, Saint Petersburg, Russian Federation","institution_ids":["https://openalex.org/I2799351582"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004836221","display_name":"Smitha Krishnamurthi","orcid":"https://orcid.org/0000-0003-2411-3504","observed_orcids":["https://orcid.org/0000-0003-2411-3504"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smitha S. Krishnamurthi","raw_affiliation_strings":["Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031031537","display_name":"Salvatore Siena","orcid":"https://orcid.org/0000-0002-2681-2846","observed_orcids":["https://orcid.org/0000-0002-2681-2846"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]},{"id":"https://openalex.org/I4210094195","display_name":"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda","ror":"https://ror.org/00htrxv69","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210094195"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Salvatore Siena","raw_affiliation_strings":["Universit\u00e0 degli Studi di Milano and Grande Ospedale Metropolitano Niguarda, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 degli Studi di Milano and Grande Ospedale Metropolitano Niguarda, Milan, Italy","institution_ids":["https://openalex.org/I189158943","https://openalex.org/I4210094195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078259926","display_name":"Wells A. Messersmith","orcid":"https://orcid.org/0000-0003-2349-0885","observed_orcids":["https://orcid.org/0000-0003-2349-0885"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wells A. Messersmith","raw_affiliation_strings":["University of Colorado Comprehensive Cancer Center, Aurora, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Comprehensive Cancer Center, Aurora, CO","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064110094","display_name":"Virgilio Souza E Silva","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019035496","display_name":"AC Camargo Hospital","ror":"https://ror.org/03025ga79","country_code":"BR","type":"healthcare","lineage":["https://openalex.org/I3019035496"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Virgilio Souza E Silva","raw_affiliation_strings":["Hospital AC Camargo Cancer Center, S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital AC Camargo Cancer Center, S\u00e3o Paulo, Brazil","institution_ids":["https://openalex.org/I3019035496"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017504528","display_name":"Andrew Scott Paulson","orcid":"https://orcid.org/0009-0000-6023-670X","observed_orcids":["https://orcid.org/0009-0000-6023-670X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Scott Paulson","raw_affiliation_strings":["Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030657436","display_name":"Elena \u00c9lez","orcid":"https://orcid.org/0000-0002-4653-6324","observed_orcids":["https://orcid.org/0000-0002-4653-6324","https://orcid.org/0000-0002-9178-0246"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena Elez","raw_affiliation_strings":["Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009132832","display_name":"Cathy Eng","orcid":"https://orcid.org/0000-0003-2335-0612","observed_orcids":["https://orcid.org/0000-0003-2335-0612"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cathy Eng","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106695967","display_name":"Sabine Tejpar","orcid":"https://orcid.org/0000-0003-3281-8643","observed_orcids":["https://orcid.org/0000-0003-3281-8643"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sabine Tejpar","raw_affiliation_strings":["UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UZ Gasthuisberg, Katholieke University Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085121407","display_name":"Michel Pierre Ducreux","orcid":"https://orcid.org/0000-0001-8649-7449","observed_orcids":["https://orcid.org/0000-0001-8649-7449"]},"institutions":[{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Pierre Ducreux","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, Institut Gustave Roussy, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, Institut Gustave Roussy, Villejuif, France","institution_ids":["https://openalex.org/I277688954","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100705618","display_name":"Wei Wu","orcid":"https://orcid.org/0000-0002-9044-0901","observed_orcids":["https://orcid.org/0000-0002-9044-0901"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei Wu","raw_affiliation_strings":["Agenus Inc., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073582280","display_name":"Joseph Elan Grossman","orcid":"https://orcid.org/0000-0002-2130-2783","observed_orcids":["https://orcid.org/0000-0002-2130-2783"]},"institutions":[{"id":"https://openalex.org/I2963242126","display_name":"Agenus (United States)","ror":"https://ror.org/03dwhj404","country_code":"US","type":"company","lineage":["https://openalex.org/I2963242126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Elan Grossman","raw_affiliation_strings":["Agenus Inc., Lexington, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agenus Inc., Lexington, MA","institution_ids":["https://openalex.org/I2963242126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090645179","display_name":"Eric Van Cutsem","orcid":"https://orcid.org/0000-0002-6372-1230","observed_orcids":["https://orcid.org/0000-0002-6372-1230"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Van Cutsem","raw_affiliation_strings":["The Ohio State University James Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University James Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155","https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101991719","display_name":"Manuel Hidalgo","orcid":"https://orcid.org/0000-0003-4977-4544","observed_orcids":["https://orcid.org/0000-0003-4977-4544"]},"institutions":[{"id":"https://openalex.org/I1340179700","display_name":"NewYork\u2013Presbyterian Hospital","ror":"https://ror.org/03gzbrs57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1340179700"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manuel Hidalgo","raw_affiliation_strings":["NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewYork-Presbyterian Hospital and Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I1340179700","https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":26,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"4_suppl","first_page":"23","last_page":"23"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8511000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8511000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.14249999821186066,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/botensilimab","display_name":"botensilimab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/balstilimab","display_name":"balstilimab","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-ctla-4-antibody","display_name":"anti-CTLA-4 antibody","score":0.8420000076293945},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.9750000238418579},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7210000157356262},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8679999709129333},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.8450000286102295},{"id":"https://openalex.org/keywords/fc-enhanced-antibody","display_name":"Fc-enhanced antibody","score":0.6320000290870667},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.734000027179718},{"id":"https://openalex.org/keywords/trifluridine-tipiracil","display_name":"trifluridine/tipiracil","score":0.9769999980926514}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9029626250267029},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.8059077262878418},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6262397766113281},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5091044306755066},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4991331100463867},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.4980621337890625},{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.4358731508255005},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41474398970603943},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.4033515751361847},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32709333300590515},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32657676935195923},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.22726494073867798},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09360745549201965},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2025.43.4_suppl.23","doi":"https://doi.org/10.1200/jco.2025.43.4_suppl.23","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2025.43.4_suppl.23","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4399640828","https://openalex.org/W4389480878","https://openalex.org/W4382806709","https://openalex.org/W4399737052","https://openalex.org/W7154705707","https://openalex.org/W4412479947","https://openalex.org/W4317863086","https://openalex.org/W7168966913","https://openalex.org/W7204535243","https://openalex.org/W4415939910"],"abstract_inverted_index":{"23":[0],"Background:":[1],"BOT":[2,51,103,116,209,264,270,286,318,322,330,343,364,395,425,428],"is":[3],"an":[4],"Fc-enhanced,":[5],"multifunctional":[6],"anti-CTLA\u22124":[7],"antibody":[8],"designed":[9],"to":[10,23,59,102,105,128,188,340,370],"improve":[11],"Fc":[12],"gamma":[13],"receptor-mediated":[14],"effector":[15],"functions":[16],"and":[17,62,81,83,198,228,268,281,295,309,387],"extend":[18],"the":[19,68,250,304,371,376],"reach":[20],"of":[21,64,71,95,133,185,200,217,306,311,392],"I-O":[22],"tumor":[24],"types":[25],"such":[26],"as":[27,241,243,338],"MSS":[28,46,166],"mCRC.":[29],"Here":[30],"we":[31],"present":[32],"preliminary":[33],"data":[34,230],"from":[35,183,383],"a":[36,403],"randomized,":[37],"open-label,":[38],"phase":[39],"2":[40,129],"study":[41,57,189,302],"in":[42,249,357,375,402],"patients":[43],"(pts)":[44],"with":[45,50,177,260,272,283,317,327,335,349,363],"mCRC":[47],"NLM":[48],"treated":[49],"\u00b1":[52],"BAL":[53,123,266,320,334,366,399,417,422],"(anti-PD\u22121;":[54],"NCT05608044).":[55],"The":[56,301],"aimed":[58],"inform":[60],"dose":[61,273,308],"contribution":[63,310],"components":[65],"based":[66,235],"on":[67],"primary":[69],"endpoint":[70],"objective":[72,355],"response":[73],"rate":[74],"(ORR)":[75],"by":[76,169,237,263],"RECIST":[77],"1.1":[78],"per":[79],"investigator,":[80],"safety,":[82],"was":[84,142,223,279,315,325],"not":[85],"powered":[86],"for":[87],"statistical":[88],"comparisons":[89],"between":[90],"arms.":[91],"Methods:":[92],"A":[93],"total":[94],"234":[96],"pts":[97],"(intent-to-treat":[98],"[ITT])":[99],"were":[100,174,258,353,367],"randomized":[101],"(up":[104,127],"4":[106],"doses)":[107],"75":[108,117,207,328,393,413,423],"or":[109,118,131,137],"150":[110,119,284,341,418,426],"mg":[111,120,125,208,212,285,289,329,333,342,346,394,398,414,416,419,421,424,427],"every":[112],"6":[113],"wks":[114],"(Q6W),":[115],"Q6W":[121],"plus":[122],"240":[124,211,288,332,345,397],"Q2W":[126],"years),":[130],"standard":[132],"care":[134],"(SOC;":[135],"regorafenib":[136],"trifluridine/tipiracil).":[138],"Results:":[139],"Median":[140],"age":[141],"58":[143],"yrs":[144],"(range":[145],"23\u201490),":[146],"50%":[147],"male,":[148],"39%":[149],"rectal,":[150],"44%":[151],"3L+,":[152],"43%":[153],"ECOG":[154],"1,":[155],"58%":[156],"KRAS":[157],"mutant,":[158,161],"4%":[159],"NRAS":[160],"83%":[162],"prior":[163],"bev,":[164],"all":[165],"and/or":[167],"pMMR":[168],"local":[170],"testing.":[171],"Key":[172,226],"characteristics":[173],"well":[175,242],"balanced":[176],"some":[178],"exceptions":[179],"including":[180],"median":[181,221],"time":[182],"diagnosis":[184],"metastatic":[186],"disease":[187],"entry":[190],"(30":[191],"mos":[192,196],"across":[193,204],"arms;":[194,205],"45":[195],"SOC)":[197],"presence":[199],"peritoneal":[201],"metastases":[202],"(34%":[203],"42%":[206],"/":[210,287,331,344,396],"BAL;":[213],"27%":[214],"SOC).":[215],"As":[216],"July":[218],"29,":[219],"2024,":[220],"follow-up":[222],"9.8":[224],"mos.":[225],"efficacy":[227],"safety":[229,293],"are":[231,381],"shown":[232],"(Table).":[233],"Image":[234],"endpoints":[236],"blinded":[238],"independent":[239],"review,":[240],"overall":[244],"survival":[245],"will":[246],"be":[247],"reported":[248],"future.":[251],"Grade":[252,454,468,484],"\u22653":[253,469],"treatment-related":[254,297],"adverse":[255],"events":[256],"(TRAEs)":[257],"highest":[259,282,326],"SOC":[261,358,401,429],"followed":[262],"+":[265,319,365],"combination,":[267],"then":[269],"monotherapy,":[271],"dependency.":[274],"Treatment-related":[275,485],"immune-mediated":[276],"diarrhea/colitis":[277],"(imDC)":[278],"manageable":[280],"BAL.":[290,347],"No":[291],"new":[292],"signals":[294],"no":[296,354],"deaths":[298],"occurred.":[299],"Conclusions:":[300],"met":[303],"objectives":[305],"informing":[307],"components.":[312],"Overall":[313],"ORR":[314,324],"higher":[316],"vs":[321,400],"monotherapy.":[323],"less":[336],"toxicity":[337],"compared":[339],"Consistent":[348],"published":[350],"data,":[351],"there":[352],"responses":[356,361,373,380],"whereas":[359],"most":[360],"seen":[362],"ongoing,":[368],"similar":[369],"durable":[372],"observed":[374],"ph1":[377],"study.":[378],"These":[379],"differentiated":[382],"previous":[384],"I-O-only":[385],"combinations":[386],"SOC,":[388],"supporting":[389],"further":[390],"investigation":[391],"planned":[404],"global":[405],"ph3":[406],"trial.":[407],"Clinical":[408],"trial":[409],"information:":[410],"NCT05608044":[411],".":[412],"BOT/240":[415,420],"ITT":[430],"(Randomized)":[431],"n=62":[432,448],"n=61":[433],"38":[434],"n=40":[435],"n=33":[436],"ORR,":[437],"%":[438],"(95%":[439],"CI)":[440],"19%(10\u201431)":[441],"8%(3\u201418)":[442],"0%(0\u201410)":[443],"8%(2\u201420)":[444],"0%(0\u201411)":[445],"Safety":[446],"(Treated)":[447],"n=60":[449],"n=37":[450],"n=39":[451],"n=21":[452],"Any":[453,483],"TRAEs,":[455,470],"n":[456,471,487],"(%)":[457,472,488],"54":[458],"(87)":[459],"59":[460],"(98)":[461],"28":[462,491],"(76)":[463],"31":[464],"(79)":[465],"19":[466,489],"(90)":[467],"22":[473],"(35)":[474,494],"25":[475],"(42)":[476],"8":[477],"(22)":[478],"9":[479],"(23)":[480],"12":[481,495],"(57)":[482],"IMDC,":[486],"(31)":[490,496],"(47)":[492],"13":[493],"0":[497],"(0)":[498]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-01-28T00:00:00"}